GT Biopharma Inc (GTBP)

Biotech Stocks: The Top 5 To Watch As Shares Broadly Struggle - Investor's Business Daily

Investor's Business Daily

FDA Approves Lilly’s Retevmo for Pediatric Indications, Non-Stimulant ADHD Drug - BioSpace

BioSpace

FDA Approves Lilly’s Retevmo for Pediatric Indications, Non-Stimulant ADHD Drug - BioSpace

BioSpace

GT Biopharma Inc (GTBP)'s financial ratios: A comprehensive overview – DWinneX - The Dwinnex

The Dwinnex

Acute Myeloid Leukemia Market Forecast 2032: FDA Approvals, Clinical Trials, Pipeline, Epidemiology and Companies ... - openPR

openPR

Acute Myeloid Leukemia Market Forecast 2032: FDA Approvals, Clinical Trials, Pipeline, Epidemiology and Companies ... - openPR

openPR

Are Smart Investors Making the Right Decision? GT Biopharma Inc (GTBP) – Sete News - SETE News

SETE News

Inotiv Inc (NOTV) Performance and Fundamentals Dashboard tells a completely different story – Sete News - SETE News

SETE News

Are Smart Investors Making the Right Decision? Calumet Specialty Products Partners L.P. (CLMT) – Sete News - SETE News

SETE News

GT Biopharma Inc (GTBP)'s Day in Review: Closing at 5.02, Down by -10.36 – DWinneX - The Dwinnex

The Dwinnex

Recap of U.S. Stock Movement and Global Market Trends - Marketing Analysis

Marketing Analysis

This trade activity should not be overlooked: GT Biopharma Inc (GTBP) – Sete News - SETE News

SETE News

Holdings of American Lithium Corp (AMLI) are aligned with the stars – Sete News - SETE News

SETE News

Borealis Foods Inc. (BRLS) Soars 77%: Analyzing the Recent Surge and Company Insights - BP Journal

BP Journal

GT Biopharma announces $3.2 million stock offering By Investing.com - Investing.com Canada

Investing.com Canada

GT Biopharma announces $3.2 million stock offering By Investing.com - Investing.com Australia

Investing.com Australia

GT Biopharma announces $3.2 million stock offering By Investing.com - Investing.com

Investing.com

GT Biopharma Shares Rise 16% After Direct Offering Prices - MarketWatch

MarketWatch

GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire Inc.

What Is Going On With GT Biopharma Inc (NASDAQ: GTBP)? – Stocks Register - Stocks Register

Stocks Register

Zenvia Inc. (ZENV) Surges 67.39% Amid Annual Report Filing and Financial Highlights - BP Journal

BP Journal

GT Biopharma (GTBP) Reports Breakthrough Q1 Results: Stock Soars 150% Amid Promising Advances - BP Journal

BP Journal

What's Going On With GT Biopharma Stock? - GT Biopharma (NASDAQ:GTBP) - Benzinga

Benzinga

GTBP’s Stock Journey: What Investors Need to Know About GT Biopharma Inc’s Performance - The InvestChronicle

The InvestChronicle

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's - Benzinga

Benzinga

What made GT Biopharma stock more than double on Monday? - InvestorsObserver

InvestorsObserver

What made GT Biopharma stock more than double on Monday? - Invezz

Invezz

What made GT Biopharma stock more than double on Monday? - TradingView

TradingView

What made GT Biopharma stock more than double on Monday? - InvestorsObserver

InvestorsObserver

GLBE, STRO and GTBP are among premarket gainers - Seeking Alpha

Seeking Alpha

US Stocks Mixed; Li Auto Shares Plummet After Q1 Results By Benzinga - Investing.com UK

Investing.com UK

US Stocks Mixed; Li Auto Shares Plummet After Q1 Results - Akoustis Technologies (NASDAQ:AKTS), GT Biopha - Benzinga

Benzinga

Why Is GT Biopharma (GTBP) Stock Up 143% Today? - InvestorPlace

InvestorPlace

Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Wix.com (NASDAQ:WIX) - Benzinga

Benzinga

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

InvestorPlace

Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Wix.com (NASDAQ:WIX) - Benzinga

Benzinga

GT Biopharma (NASDAQ:GTBP) Trading Down 4.6% - Defense World

Defense World

Oragenics, Inc (NYSE: OGEN) Surges 34% Amidst Webinar Announcement and Intranasal Pharmaceutical Development - BP Journal

BP Journal

Safe & Green Holdings Corp (NASDAQ: SGBX): A Strong Surge Amid Promising Developments - BP Journal

BP Journal

Nuburu Inc (NYSE: BURU) Surges Amid Exciting Developments - BP Journal

BP Journal

GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - 15.05.2024 - wallstreet:online

wallstreet:online

Biotech Stocks: The Top 5 To Watch As Shares Trend Down - Investor's Business Daily

Investor's Business Daily

What's the Difference Between Biotech Stocks and TechBio Stocks? - Yahoo Finance

Yahoo Finance

GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - 15.05.2024 - wallstreet:online

wallstreet:online

The diverse modalities targeting B7-H3 - BioCentury

BioCentury

GT Biopharma Inc expected to post a loss of $2.70 a share - Earnings Preview - XM

XM

Here's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock Now - Yahoo News Australia

Yahoo News Australia

Is GT Biopharma, Inc. (NASDAQ:GTBP) Popular Amongst Insiders? - Yahoo Movies UK

Yahoo Movies UK

NK Cell Therapy Pipeline Outlook, Clinical Trials, FDA Approvals, and Companies 2024 (Updated) - openPR

openPR

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - Yahoo Finance

Yahoo Finance